Counterpoint Mutual Funds LLC Takes Position in Orthofix Medical Inc. $OFIX

Key Points

• Counterpoint Mutual Funds LLC has acquired 26,968 shares of Orthofix Medical Inc. valued at approximately $301,000, marking their entry into the company during the second quarter.
• Orthofix Medical reported a loss of ($0.36) earnings per share for its latest quarter, significantly below the expected $0.04, while total revenue was $203.12 million, surpassing estimates.
• Several analysts maintain a moderate buy rating on Orthofix Medical, with a target price of $21.75, indicating optimism for future growth despite recent earnings performance.

Counterpoint Mutual Funds LLC purchased a new stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 26,968 shares of the medical device company's stock, valued at approximately $301,000. Counterpoint Mutual Funds LLC owned about 0.07% of Orthofix Medical as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. US Bancorp DE increased its position in shares of Orthofix Medical by 684.6% during the 1st quarter. US Bancorp DE now owns 5,673 shares of the medical device company's stock valued at $93,000 after purchasing an additional 4,950 shares during the last quarter. Strs Ohio purchased a new stake in shares of Orthofix Medical during the 1st quarter valued at about $150,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new stake in shares of Orthofix Medical during the 1st quarter valued at about $164,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Orthofix Medical by 42.5% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,053 shares of the medical device company's stock valued at $229,000 after purchasing an additional 4,192 shares during the last quarter. Finally, XTX Topco Ltd increased its position in shares of Orthofix Medical by 48.9% during the 1st quarter. XTX Topco Ltd now owns 19,929 shares of the medical device company's stock valued at $325,000 after purchasing an additional 6,541 shares during the last quarter. Hedge funds and other institutional investors own 89.76% of the company's stock.

Orthofix Medical Price Performance

Shares of NASDAQ:OFIX opened at $14.80 on Thursday. Orthofix Medical Inc. has a 1-year low of $10.24 and a 1-year high of $20.73. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.67 and a quick ratio of 1.50. The company has a market capitalization of $584.45 million, a P/E ratio of -4.67 and a beta of 0.86. The firm's 50 day simple moving average is $13.52 and its two-hundred day simple moving average is $13.14.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The medical device company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.40). Orthofix Medical had a negative return on equity of 25.43% and a negative net margin of 15.29%.The business had revenue of $203.12 million during the quarter, compared to the consensus estimate of $196.89 million. Orthofix Medical has set its FY 2025 guidance at EPS. Research analysts expect that Orthofix Medical Inc. will post -2.81 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Barrington Research reaffirmed an "outperform" rating and set a $17.00 price target on shares of Orthofix Medical in a research report on Tuesday. JMP Securities reaffirmed a "market perform" rating on shares of Orthofix Medical in a report on Friday, June 6th. Finally, Wall Street Zen raised shares of Orthofix Medical from a "sell" rating to a "hold" rating in a report on Saturday, August 9th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $21.75.

Orthofix Medical Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.